Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NERVGEN-PHARMA-CORP-55763923/news/Nervgen-Pharma-Corp-Receives-Institutional-Review-Board-Approval-for-Its-Phase-1B-2A-Proof-Of-Conce-44597599/?utm_source=whatsapp&utm_medium=social&utm_campaign=share